0001209191-20-032143.txt : 20200526
0001209191-20-032143.hdr.sgml : 20200526
20200526175517
ACCESSION NUMBER: 0001209191-20-032143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Countouriotis Athena
CENTRAL INDEX KEY: 0001571469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38871
FILM NUMBER: 20912118
MAIL ADDRESS:
STREET 1: C/O AMBIT BIOSCIENCES CORPORATION
STREET 2: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc.
CENTRAL INDEX KEY: 0001595893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463826166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-926-5251
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, Inc.
DATE OF NAME CHANGE: 20181018
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, INC
DATE OF NAME CHANGE: 20140106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-21
0
0001595893
Turning Point Therapeutics, Inc.
TPTX
0001571469
Countouriotis Athena
C/O TURNING POINT THERAPEUTICS, INC.
10628 SCIENCE CENTER DRIVE, STE. 200
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2020-05-21
4
P
0
4166
60.00
A
26872
D
The shares were purchased in connection with the Issuer's public offering.
/s/ Annette North, Attorney-in-Fact
2020-05-26